Smoking Treatment of Prisoners

Completed · Phase 3

Conditions studied: Tobacco Use Cessation, Tobacco Use Disorder

In brief

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Key facts

Study ID

NCT00110630

Run by

National Institute on Drug Abuse (NIDA)

People needed

250

Starts

2005-06-01

Expected to finish

2007-09-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 1) current smoker and (2) seeking group treatment to quit smoking.

You may not qualify if…

• (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.

Where it is running

• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.